Lisinopril And Hydrochlorothiazide Tablet
NDC Package 68071-2183-9

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Lisinopril And Hydrochlorothiazide tablets is classified as a

administered via oral route. This formulation utilizes a tablet delivery system. Marketed by Nucare Pharmaceuticals,inc., this product is identified by NDC 68071-2183 and is authorized under FDA application ANDA077912.

Identification & Billing

NDC Package Code
68071-2183-9
Package Description
90 TABLET in 1 BOTTLE
Product Code
68071-2183
11-Digit Billing Format
68071218309
RxNorm Crosswalk
  • RxCUI: 197885 - lisinopril 10 MG / hydroCHLOROthiazide 12.5 MG Oral Tablet
  • RxCUI: 197885 - hydrochlorothiazide 12.5 MG / lisinopril 10 MG Oral Tablet
  • RxCUI: 197885 - HCTZ 12.5 MG / lisinopril 10 MG Oral Tablet

Clinical Specifications

Proprietary Name
Lisinopril And Hydrochlorothiazide
Non-Proprietary Name
Lisinopril And Hydrochlorothiazide
Substance Name
Hydrochlorothiazide; Lisinopril
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class

Regulatory & Marketing

Labeler Name
Nucare Pharmaceuticals,inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA077912
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
10-04-2006
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68071-2183-9 identifies a specific commercial package of 90 tablet in 1 bottle of Lisinopril And Hydrochlorothiazide, a human prescription drug labeled by Nucare Pharmaceuticals,inc.. This tablet is formulated for oral use and contains hydrochlorothiazide; lisinopril as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Nucare Pharmaceuticals,inc. on October 04, 2006. The current certification is valid through December 31, 2026.

How is this Nucare Pharmaceuticals,inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68071218309. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
68071-2183-9
11-Digit CMS (5-4-2)
68071-2183-09

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.